Ahmed Sakir, Grainger Rebecca, Santosa Anindita, Adnan Asal, Alnaqbi Khalid A, Chen Yi-Hsing, Kavadichanda Chengappa, Kaw Nang San Kyauk, Kelly Amy, Khan Saira Elaine Anwer, Masri Basel, Nakarmi Shweta, Parlindungan Faisal, Rahman Nazibur, So Ho, Soroush Mohsen Ghasemzadeh, Thilakarathne Amal Sithira, Traboco Lisa
Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences, Bhubaneswar, India.
Department of Medicine, University of Otago, Wellington, New Zealand.
Int J Rheum Dis. 2022 Mar;25(3):247-258. doi: 10.1111/1756-185X.14286. Epub 2022 Jan 19.
The COVID-19 pandemic led to rapid and widespread adoption of telemedicine in rheumatology care. The Asia Pacific League of Associations for Rheumatology (APLAR) working group was tasked with developing evidence-based recommendations for rheumatology practice to guide maintenance of the highest possible standards of clinical care and to enable broad patient reach.
A systematic review of English-language articles related to telehealth in rheumatology was conducted on MEDLINE/PubMed, Web Of Science and Scopus. The strength of the evidence was graded using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach as well as the Oxford Levels of Evidence. The recommendations were developed using a modified Delphi technique to establish consensus.
Three overarching principles and 13 recommendations were developed based on identified literature and consensus agreement. The overarching principles address telemedicine frameworks, decision-making, and modality. Recommendations 1-4 address patient suitability, triage, and when telemedicine should be offered to patients. Recommendations 5-10 cover the procedure, including the means, data safety, fail-safe mechanisms, and treat-to-target approach. Recommendations 11-13 focus on training and education related to telerheumatology.
These recommendations provide guidance for the approach and use of telemedicine in rheumatology care to guide highest possible standards of clinical care and to enable equitable patient reach. However, since evidence in telemedicine care in rheumatology is limited and emerging, most recommendations will need further consideration when more data are available.
新冠疫情导致远程医疗在风湿病护理中迅速且广泛地得到应用。亚太风湿病协会联盟(APLAR)工作组的任务是制定基于证据的风湿病诊疗建议,以指导维持尽可能高的临床护理标准,并确保广泛惠及患者。
在MEDLINE/PubMed、科学网和Scopus上对与风湿病远程医疗相关的英文文章进行了系统综述。使用推荐分级、评估、制定与评价(GRADE)方法以及牛津证据等级对证据强度进行分级。通过改良的德尔菲技术达成共识来制定这些建议。
基于已识别的文献和共识意见,制定了三项总体原则和13条建议。总体原则涉及远程医疗框架、决策制定和模式。建议1 - 4涉及患者适用性、分诊以及何时应向患者提供远程医疗服务。建议5 - 10涵盖诊疗程序,包括方式、数据安全、故障安全机制和达标治疗方法。建议11 - 13关注与远程风湿病学相关的培训和教育。
这些建议为远程医疗在风湿病护理中的应用方法提供了指导,以指导尽可能高的临床护理标准,并确保公平地惠及患者。然而,由于风湿病远程医疗护理的证据有限且仍在不断涌现,当有更多数据可用时,大多数建议将需要进一步考虑。